Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Cooleys Anemia Foundation

- PMLiVE

Celgene’s Revlimid wins US lymphoma approval

FDA recommends extra indication for blockbuster cancer drug

- PMLiVE

EMA backs Pomalidomide Celgene in multiple myeloma

Further positive CHMP opinions for new medicines form Aegerion, Teva and more

- PMLiVE

Clinical trials for EMA-submitted medicines move away from US and Europe

Most trial patients for drug marketing applications to EMA now come from rest of the world

- PMLiVE

Future imperfect: How breakthrough technology can support healthcare

Current economic strategies are fundamentally flawed and the age of plenty is coming to an end, according one self-professed futurist. Could breakthrough technologies save humankind from a sticky end?

- PMLiVE

Celgene promotes Karen Browne to haematology director

She takes up a new role with the company's UK and Ireland business

China: Engagement strategies

As China grows apace, digital is increasingly being used to engage both customers and patients

- PMLiVE

Celgene’s apremilast set for 2013 filing

Pharma company releases positive phase III results for psoriasis candidate

- PMLiVE

Technology trends facing pharma in 2013

Context-based services and social media are among the major technology trends pharma will need to embrace in 2013

- PMLiVE

Celgene gets US green light for blockbuster candidate Pomalyst

FDA approval to treat multiple myeloma

- PMLiVE

Eric Green named NIH’s data science lead

Takes role on interim basis as part of expanding plans for data

- PMLiVE

Sarah Bater joins Celgene

Will head human resources in UK and Ireland

- PMLiVE

Celgene signs $500m antibody deal with Sutro

Joins list of companies with interest in antibody-drug conjugates

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links